Erratum

A Correction to the Perspective Titled: "GIP: No Longer the Neglected Incretin Twin?" by Rohit N. Kulkarni

Science Translational Medicine  22 Sep 2010:
Vol. 2, Issue 50, pp. 50er2
DOI: 10.1126/scitranslmed.3001721

There was an error in Fig. 1. The label for the pancreas should have read “enhance insulin secretion” instead of “enhance glucose secretion.” The correct version of Fig. 1 appears here: http://stm.sciencemag.org/content/2/49/49ps47.full.pdf.

In addition, in the PDF version of the article, reference 36 was truncated. The correct reference is:

36. S. J. Kim, C. Nian, C. H. McIntosh, Glucose-dependent insulinotropic polypeptide (GIP) increases human adipocyte lipoprotein lipase (LPL) expression through cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2 (TORC2) mediated trans-activation of the LPL gene. J. Lipid Res. 7 August 2010 (10.1194/jlr.M006841).

Published 22 September 2010

10.1126/scitranslmed.3001721

Footnotes

    • Citation: A Correction to the Perspective Titled: "GIP: No Longer the Neglected Incretin Twin?" by Rohit N. Kulkarni Sci. Transl. Med. 2, 50er2 (2010).

    Navigate This Article